scholarly journals Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non‑small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report

2018 ◽  
Author(s):  
Teppei Yamaguchi ◽  
Yusuke Gotoh ◽  
Hidekazu Hattori ◽  
Hidetoshi Katsuno ◽  
Kazuyoshi Imaizumi
Sign in / Sign up

Export Citation Format

Share Document